Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

Literature DB >> 12477751

Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

H Barr¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2003 PMID： 12477751 PMCID： PMC1773500 DOI： 10.1136/gut.52.1.14

Source DB: PubMed Journal: Gut ISSN： 0017-5749 Impact factor: 23.059

× No keyword cloud information.

18 in total

1. Long-term follow-up of Barrett's high-grade dysplasia.

Authors: A P Weston; P Sharma; M Topalovski; R Richards; R Cherian; A Dixon
Journal: Am J Gastroenterol Date: 2000-08 Impact factor: 10.864

2. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus.

Authors: E Bollschweiler; W Schröder; A H Hölscher; J R Siewert
Journal: Br J Surg Date: 2000-08 Impact factor: 6.939

3. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.

Authors: C Ell; A May; L Gossner; O Pech; E Günter; G Mayer; R Henrich; M Vieth; H Müller; G Seitz; M Stolte
Journal: Gastroenterology Date: 2000-04 Impact factor: 22.682

4. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.

Authors: N S Buttar; K K Wang; T J Sebo; D M Riehle; K K Krishnadath; L S Lutzke; M A Anderson; T M Petterson; L J Burgart
Journal: Gastroenterology Date: 2001-06 Impact factor: 22.682

5. Barrett's metaplasia.

Authors: J A Jankowski; R F Harrison; I Perry; F Balkwill; C Tselepis
Journal: Lancet Date: 2000-12-16 Impact factor: 79.321

6. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Authors: E Montgomery; M P Bronner; J R Goldblum; J K Greenson; M M Haber; J Hart; L W Lamps; G Y Lauwers; A J Lazenby; D N Lewin; M E Robert; A Y Toledano; Y Shyr; K Washington
Journal: Hum Pathol Date: 2001-04 Impact factor: 3.466

7. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.

Authors: R Ackroyd; N J Brown; M F Davis; T J Stephenson; S L Marcus; C J Stoddard; A G Johnson; M W Reed
Journal: Gut Date: 2000-11 Impact factor: 23.059

8. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.

Authors: J H Peters; G W Clark; A P Ireland; P Chandrasoma; T C Smyrk; T R DeMeester
Journal: J Thorac Cardiovasc Surg Date: 1994-11 Impact factor: 5.209

9. Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers.

Authors: M O Bachmann; D Alderson; D Edwards; S Wotton; C Bedford; T J Peters; I M Harvey
Journal: Br J Surg Date: 2002-07 Impact factor: 6.939

Ablative mucosectomy is the procedure of choice to prevent Barrett's cancer.

1. Long-term follow-up of Barrett's high-grade dysplasia.

2. Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus.

3. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett's esophagus.

4. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma.

5. Barrett's metaplasia.

6. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

7. Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.

8. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients.

9. Cohort study in South and West England of the influence of specialization on the management and outcome of patients with oesophageal and gastric cancers.

10. Determinants of survival following the diagnosis of esophageal adenocarcinoma (United States).

Review 1. Endoscopic therapy for Barrett's oesophagus.

Review 2. Barrett's oesophagus: the new endoscopic modalities have a future.

Review 3. Endoscopic therapies for Barrett's neoplasia.

4. Barrett's oesophagus and adenocarcinoma.